MINNEAPOLIS, Aug. 27, 2025 -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:
2025 Wells Fargo Healthcare Conference
September 3, 2025
10:15 AM EDT
Baird 2025 Global Healthcare Conference
September 9, 2025
9:05 AM EDT
Morgan Stanley 23rd Annual Global Healthcare Conference
September 10, 2025
10:45 AM EDT
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.
This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology.
